Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001062993-23-018542

Director bought 676,371 shares at $1.85 ($1,249,934)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kavuru Vimal Director 2023-09-25 Purchase +676,371 $1.85 $1,249,934 1,188,076 I
Derivatives
Kavuru Vimal Director 2023-09-25 Purchase · Common Warrants (right to buy) +422,732 $0.13 $52,842 422,732 I
Open-market purchases · 676,371 sh · avg $1.85 · $1,249,934
Loading xslF345X05/form4.xml…